This compound is a fluorinated nitroquinazoline derivative used as a pharmaceutical intermediate in the manufacturing of afatinib impurities. Its structure features multiple halogen and amine functional groups, contributing to its role in research and development.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 2226537-61-5
N-(4-Chloro-3-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
pharmaceutical intermediate
N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
Pharmaceutical intermediate for drug synthesis
N-(3,4-Dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
impurity reference standard for afatinib
(R)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((R)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide
Pharmaceutical intermediate for afatinib impurities
(R)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine
Pharmaceutical intermediate for afatinib impurities
2-Bromo-5-(4-cyanophenoxy)benzyl acetate
Pharmaceutical intermediate
Methyl 4-[(1S)-1-aminoethyl]benzoate
pharmaceutical intermediate
(R)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol
Pharmaceutical intermediate for synthesis
N-(3,4-difluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
DZRYHCITHKPDFS-UHFFFAOYSA-N
C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])F)F)F
—